Advertisement · 728 × 90
#
Hashtag
#ND0612
Advertisement · 728 × 90
Preview
Mitsubishi Tanabe Pharma America to Unveil New Findings on ND0612 at 2025 International Congress of Parkinson's Disease Mitsubishi Tanabe Pharma America will present vital data on ND0612, a treatment for Parkinson's disease, at the 2025 International Congress in Honolulu. Join us to explore the innovative research.

Mitsubishi Tanabe Pharma America to Unveil New Findings on ND0612 at 2025 International Congress of Parkinson's Disease #USA #Honolulu #Parkinson's_Disease #ND0612 #Mitsubishi_Pharma

0 0 0 0
Preview
Mitsubishi Tanabe Pharma Showcases Latest Parkinson's Research at Upcoming 2025 Events Mitsubishi Tanabe Pharma America will present groundbreaking Parkinson's disease research at the 2025 EAN and ATMRD congresses, focusing on ND0612.

Mitsubishi Tanabe Pharma Showcases Latest Parkinson's Research at Upcoming 2025 Events #USA #Parkinson's_Disease #Jersey_City #Mitsubishi_Tanabe_Pharma #ND0612

0 0 0 0
Preview
Mitsubishi Tanabe Pharma America to Present New Neurodegenerative Research Findings at AAN 2025 Annual Meeting Mitsubishi Tanabe Pharma America will showcase 11 studies at AAN 2025, focusing on breakthroughs in Parkinson's and ALS therapies.

Mitsubishi Tanabe Pharma America to Present New Neurodegenerative Research Findings at AAN 2025 Annual Meeting #United_States #San_Diego #Mitsubishi_Tanabe #RADICAVA #ND0612

0 0 0 0
Preview
Mitsubishi Tanabe Pharma to Present Groundbreaking ND0612 Data at 2025 AD/PD Conference Mitsubishi Tanabe Pharma America will present crucial data on ND0612 for Parkinson's disease at the upcoming 2025 AD/PD conference in Vienna, Austria.

Mitsubishi Tanabe Pharma to Present Groundbreaking ND0612 Data at 2025 AD/PD Conference #United_States #Parkinson's_Disease #Jersey_City #Mitsubishi_Tanabe #ND0612

0 0 0 0
Preview
Mitsubishi Tanabe Pharma America to Showcase ND0612 Research at Parkinson Study Group Annual Meeting 2024 Mitsubishi Tanabe Pharma America will present pivotal data on investigational ND0612 during the Parkinson Study Group Annual Meeting in Nashville, shedding light on new treatment avenues.

Mitsubishi Tanabe Pharma America to Showcase ND0612 Research at Parkinson Study Group Annual Meeting 2024 #United_States #Nashville #Parkinson's_Disease #Mitsubishi_Tanabe #ND0612

1 0 0 0